We are live on ! Find out more

Intuitive Surgical

ISRG

Market cap $131B

371.84 USD

-1.73

0.46%

At close Updated Aug 25, 4:00 PM EDT

Pre-market

After hours

372.38

+0.54

0.15%

1 day

-0.46%

5 days

-5.76%

1 month

4.21%

3 months

-14.84%

6 months

-26.54%

Year to date

-33.83%

1 year

-20.62%

5 years

6.85%

10 years

387.53%

About: Intuitive develops, produces, and markets a robotic system for assisting minimally invasive surgery. It also provides the instrumentation, disposable accessories, and warranty services for the system. The company has placed more than 10,000 da Vinci systems in hospitals worldwide, with more than 6,000 installations in the US and a growing number in emerging markets.

Employees: 17,021

Healthcare Medical Instruments & Supplies

News

Positive

Neutral

Negative

Sentiment 3-Months

Positive 54.2%

Neutral 25.8%

Negative 20%

Zacks Investment Research

Wall Street Bulls Look Optimistic About Intuitive Surgical (ISRG): Should You Buy?

When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts often influence a stock's price, but are they really important?

Wall Street Bulls Look Optimistic About Intuitive Surgical (ISRG): Should You Buy?

Zacks Investment Research

Intuitive Surgical Expands Manufacturing Footprint in Asia Pacific

ISRG is expanding in Asia Pacific with a new Penang plant to boost capacity and support rising demand for robotic-assisted surgery.

Intuitive Surgical Expands Manufacturing Footprint in Asia Pacific

The Motley Fool

Intuitive Surgical Stock Is Having Its Worst Year Since 2008. What's Behind the Sell-Off?

Intuitive's revenue growth came in at 19% in its most recent quarter. The company's full-year guidance for procedures, however, was underwhelming and lower than the most recent quarter.

Intuitive Surgical Stock Is Having Its Worst Year Since 2008. What's Behind the Sell-Off?

The Motley Fool

Thinking About Buying SpaceX? These 2 Stocks Should Be Better Bets

SpaceX seems promising, but the stock looks too expensive at current levels. Intuitive Surgical has lagged broader equities this year, but it's a great buy on the dip.

Thinking About Buying SpaceX? These 2 Stocks Should Be Better Bets

Zacks Investment Research

Is ISRG's Software Strategy Becoming as Important as Its Robots?

ISRG's software roadmap is strengthening da Vinci 5, with new features, renewals and recurring service revenues reinforcing its digital ecosystem.

Is ISRG's Software Strategy Becoming as Important as Its Robots?

Zacks Investment Research

ISRG's US Procedure Growth Slows: Is ACA Headwind a Temporary Concern?

ISRG's US procedure growth slows in Q2, but ACA-related care deferrals may prove temporary as underlying demand and da Vinci 5 adoption remain strong.

ISRG's US Procedure Growth Slows: Is ACA Headwind a Temporary Concern?

Intuitive Surgical: Priced For Precision

Intuitive Surgical is rated a Hold, with a modeled +9.17% upside and a price target of $426.65. ISRG's growth thesis centers on untapped ASC procedure volume, overstated remanufacturing risks, and remanufacturing's role in expanding the installed base. Remanufacturing currently poses a limited threat, with sub-3% penetration and approval for only 4 out of 45+ instruments.

Intuitive Surgical: Priced For Precision

This Intuitive Surgical Analyst Turns Bullish; Here Are Top 4 Upgrades For Wednesday

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.

This Intuitive Surgical Analyst Turns Bullish; Here Are Top 4 Upgrades For Wednesday

The Motley Fool

Intuitive Surgical (ISRG) Stock Has Plunged 33% in 2026. Here's Why One Fund Manager Remains Bullish -- and Why I Do, Too.

The robotic surgery specialist has over 12,000 installed systems globally. Right now, it's facing some headwinds, but it also has a lot going for it.

Intuitive Surgical (ISRG) Stock Has Plunged 33% in 2026. Here's Why One Fund Manager Remains Bullish -- and Why I Do, Too.

24/7 Wall Street

The Number One Reason I Keep Buying Intuitive Surgical Now For The Long Run

I keep hitting the buy button on Intuitive Surgical (NASDAQ:ISRG | ISRG Price Prediction), and the recent drawdown has only made me press it harder.

The Number One Reason I Keep Buying Intuitive Surgical Now For The Long Run

See News Rankings

Price charts implemented using Lightweight Charts™